In a new study published in Nature titled, “Custom CRISPR-Cas9 PAM variants via scalable engineering and machine learning,” researchers from Massachusetts General Hospital (MGH) and Harvard Medical ...
Researchers in the Nanoscience Center at the University of Jyväskylä, Finland, have developed a pioneering computational model that could expedite the use of nanomaterials in biomedical applications.
An international team led by Einstein Professor Cecilia Clementi in the Department of Physics at Freie Universität Berlin introduces a breakthrough in protein simulation. The study, published in the ...
CGSchNet, a fast machine-learned model, simulates proteins with high accuracy, enabling drug discovery and protein engineering for cancer treatment. Operating significantly faster than traditional all ...
AZoLifeSciences on MSN
Machine learning enhances manufacturing of complex protein drugs
Industrial yeasts are a powerhouse of protein production, used to manufacture vaccines, biopharmaceuticals, and other useful compounds.
Machine learning is an essential component of artificial intelligence. Whether it’s powering recommendation engines, fraud detection systems, self-driving cars, generative AI, or any of the countless ...
A platform to engineer enzymes responsible for the formation of amide bonds as an effort toward developing biocatalysts for green chemistry. Amide bonds — a type of chemical bond formed between a ...
In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.
A generalizable ML framework predicts protein interactions with ligand-stabilized gold nanoclusters, supporting faster design of bioimaging, sensing and drug delivery materials. (Nanowerk News) The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results